SAGE CENTRAL

Serial Number 88466494
Registration 6148701
700

Registration Progress

Application Filed
Jun 10, 2019
Under Examination
Dec 3, 2019
Approved for Publication
Oct 8, 2019
Published for Opposition
Oct 8, 2019
Registered
Sep 8, 2020

Basic Information

Serial Number
88466494
Registration Number
6148701
Filing Date
June 10, 2019
Registration Date
September 8, 2020
Published for Opposition
October 8, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 8, 2020
Registration
Registered
Classes
044

Rights Holder

Sage Therapeutics, Inc.

03
Address
55 Cambridge Parkway
Suite 401
Cambridge, MA 02142

Ownership History

Sage Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sage Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sage Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

Next Deadline
427 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-09-08)
Due Date
September 08, 2026
Grace Period Ends
March 08, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description
Mar 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Aug 4, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 3, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 8, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2020 GNRT F NON-FINAL ACTION E-MAILED
Jul 5, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN
Jul 5, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 15, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 11, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 20, 2020 IUAF S USE AMENDMENT FILED
May 20, 2020 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 10, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 3, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2019 PUBO A PUBLISHED FOR OPPOSITION
Sep 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 30, 2019 DOCK D ASSIGNED TO EXAMINER
Jun 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Providing health and medical information about postpartum depression and treatment; patient support services relating to the treatment of postpartum depression, namely, providing a web site for medical professionals and patients featuring information relating to postpartum depression; patient support services, namely, pharmaceutical advice and consultation in the nature of providing online medical information regarding postpartum depression and treatment
First Use Anywhere: Jul 1, 2019
First Use in Commerce: Jul 1, 2019

Classification

International Classes
044